We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




MEDICA 2022 to Take a Look at New Digital Reality and Revolutionary Technologies

By LabMedica International staff writers
Posted on 10 Oct 2022

As one of the world's leading medical trade fairs, MEDICA (Düsseldorf, Germany) in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. More...

Among the over 4,200 companies at MEDICA 2022 (duration: 14 – 17 November) there will again be several hundred start-ups. This event, which is one of the most international trade fairs (more than 70% of all visitors hail from abroad, and about 150 nations overall are represented), is a gateway to the world for them, through which they can make contacts across all continents.

One example is the MEDICA CONNECTED HEALTHCARE FORUM (in Hall 12), a special platform for young entrepreneurs. The most important issues of the four-day-program for the year 2022 are: Connected medical things, AI & big data, robotics, the health metaverse, the future of hospitals and care centers, health monitoring and diagnostics, mobile health, digital therapeutics, mental health, and more. About a hundred chosen start-ups and scale-ups present themselves on the forum stage during the MEDICA DISRUPT Sessions. The finale of the 11th MEDICA Start-Up COMPETITION and the "14th Healthcare Innovation World Cup" are highlights of the program.

The 11th MEDICA Start-Up COMPETITION is on the lookout for innovative healthcare industry solutions, from health apps and new tools for gathering and AI-supported analysis of health data, to robotic assistance systems and new approaches in diagnostics. Until mid-September, hundreds of innovators had already registered their participation in the finale of the competition during MEDICA 2022. The 12 best finalists, chosen by a professional jury, will now pitch on 15 November at 1 p.m. to win the grand prize. A day before, on 14 November at 1 p.m., the finale for the "14th Healthcare Innovation World Cup" will start. There, another 12 chosen finalists will pitch to win with their solutions for the "Internet of Medical Things" (IoMT). The span of developments reaches from interconnected medical technological devices, wearable technologies, digital biomarkers and intelligent plasters up to smart implants.

In addition, the metaverse is going to be one of the important topics at the MEDICA CONNECTED HEALTHCARE FORUM. The new buzzword hints at a novel digital reality that focuses on technologies like virtual reality (VR) and augmented reality (AR), the possibilities of processing big data in real time by artificial intelligence, and digital twins. This could lead to revolutionary changes in health care, both for monitoring health and treatments. This trend provides the focus for the content of a symposium, starting on Wednesday, 16 November, at 12 p.m. There, Eva Garcia Ramos, CEO and co-founder of WIVI Vision, will speak. The start-up concentrates mostly on children and adolescents. The products (for example with the capacity for 3D visualization) aim to improve health care with a view to evaluating and treating problems with visual function.

Khora, a Danish start-up, will also be present on stage at the MEDICA CONNECTED HEALTHCARE FORUM. The start-up has worked with the Rigshospitalet to create, for example, an AR universe aimed at children and adolescents from ages ten to fourteen, who have to spend considerable time in hospital with cancer or leukemia. It is supposed to make daily life easier for them. Khora created "Snail Battle", which allows persons affected to use plants to fight against evil monster snails. During the MEDICA CONNECTED HEALTHCARE FORUM, CEO Simon Lajboschitz will also explain, how VR can help patients with schizophrenia affected by auditory hallucinations. The metaverse can offer opportunities in many other areas, ranging from applications for attention deficit disorder over the development and testing of medical devices on virtual patients to simulation scenarios. These will be the focus of talks on Wednesday, 16 November.

Thericon and KuartisMED are among the companies participating in the MEDICA START-UP PARK. The shared booth (also located in Hall 12) has established itself over the years as a central meeting point for business and networking with the young founders' scene, and this year counts around 40 participants. German start-up Thericon see themselves as the first company to bring imaging compiled from several different sources into the operating theatre as a visual aid. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and their intuitive display aims to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. Meanwhile, Turkish company KuartisMED concentrates on innovative solutions for the well-being of newborns. As children born before the 34th week of gestation lack sufficient coordination of the sucking and swallowing reflexes, they depend on feeding tubes for nutrition. The non-invasive medical device by KuartisMED aims to help with evaluating the maturity of these reflexes in the future. These aforementioned examples show that for those interested in innovations in the health sector, a visit to MEDICA 2022, and especially the novelties presented by the various start-ups, is a must.

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.